Table 3

Univariate analysis showing baseline predictors of sustained LLDAS, LLDAS5 and remission according to DORIS definitions

Baseline predictors	LLDAS	LDAS5	RONT	ROFT	Complete RONT	Complete ROFT
Age	NS	NS	NS	NS	NS	NS
Disease duration	NS	NS	NS	NS	NS	NS
Recent onset	NS	NS	NS	NS	NS	NS
Mean SLEDAI	P<0.001	P<0.001	P=0.001	NS	P=0.02	NS
SLEDAI>4	P<0.001	P<0.001	P=0.001	NS	P=0.07	NS
Only serological activity	NS	NS	NS	P=0.015	P=0.04	NS
Previous major organ involvement	NS	NS		NS	NS	NS
Articular manifestations	P=0.004	P<0.001	P=0.01	NS	NS	NS
Mucocutaneous manifestations	P=0.02	P=0.12	P=0.02	NS	NS	NS
Renal manifestations	NS	P=0.02	NS	NS	NS	NS
Neuropsychiatric manifestations	NS	NS	NS	NS	NS	NS
Serositis/haematological manifestations	NS	NS	NS	NS	NS	NS
Therapy with HCQ	NS	NS	NS	NS	NS	NS

DORIS, Definition of Remission in SLE; HCQ, hydroxychloroquine; LLDAS, lupus low disease activity state; LLDAS5, LLDAS with a GC dosage ≤5; NS, not significant; ROFT, remission OFF treatment; RONT, remission ON treatment; SLEDAI, SLE Disease Activity Index.